But was removed later.

Gatifloxacin – a new type of fluoroquinolone – was released in North America in 1999 under the brand name Tequin by the pharmaceutical company Bristol-Myers Squibb, but was removed later, after the publication in 2006 Canada , a retrospective study in the New England Journal of medicine found that the drug can cause serious side effects including is very high and low blood sugar.

Hypertension in 7 in 7 of 15 patients, and in five of the patients had osteoporosis. Eye examinations showed myopia in 10 of the patients and cataracts in three of the patients. In the eight male participants in the study, low sperm count was found in one patient, reduced sperm motility in four patients identified and defective sperm were present in six patients.Ponder International, plurality of states powerful activities, Lobstein noticed Brazilian creating legislation on television advertisements, in Thailand legislative to increase the amount of advertising on children must necessarily be limited. During this decade to are banning junk foods marketing, kids, during South African, Colombia and Chile who been waiting for a draft law, he said.

Other entries from category "medicine":

Random entries